SAN DIEGO, June 13, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase biology platform, today announced that Leslie A. Nangle, Ph.D., Vice President, Research at aTyr, will present at the International 28th tRNA Conference, which is scheduled to take place June 12 – 16, 2022, at The Ohio State University in Columbus, OH.
Read more at globenewswire.comaTyr Pharma to Present Findings from its tRNA Synthetase Platform at the International 28th tRNA Conference
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
